Related Experiment Video
Updated: Jul 19, 2026

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
Published on: July 29, 2011
Newly acquired right bundle-branch block: The Framingham Study
Insights
Developing complete right bundle-branch block (RBBB) indicates significant cardiovascular risks. Individuals with RBBB face increased coronary disease, heart failure, and cardiovascular mortality, highlighting the need for proactive cardiac evaluation.
Area of Science:
- Cardiology
- Epidemiology
- Clinical Medicine
Background:
- Right bundle-branch block (RBBB) is a cardiac conduction abnormality.
- The long-term cardiovascular implications of RBBB require further elucidation.
Purpose of the Study:
- To prospectively investigate the association between the development of complete right bundle-branch block (RBBB) and subsequent cardiovascular abnormalities and mortality.
- To identify electrocardiographic predictors of associated cardiovascular conditions in individuals with new-onset RBBB.
Main Methods:
- Prospective observational study within The Framingham Study cohort over 18 years.
- Biennial follow-up assessments including electrocardiograms (ECGs) and clinical evaluations.
- Comparison of cardiovascular disease incidence and mortality between subjects who developed RBBB and matched controls.
Main Results:
- All 70 individuals who developed RBBB had associated cardiovascular abnormalities; only 21% were free from clinically apparent conditions.
- Subsequent incidence of coronary disease and congestive heart failure was significantly higher in the RBBB group compared to controls.
- Cardiovascular disease mortality was nearly three times greater in the RBBB group, primarily due to associated abnormalities.
- A QRS duration ≥130 ms and a QRS axis between -45° and -90° were associated with a higher likelihood of coexisting cardiovascular abnormalities.
Conclusions:
- The development of complete RBBB is strongly linked to a high prevalence of underlying cardiovascular abnormalities.
- New-onset RBBB portends a significantly increased risk of future coronary disease, congestive heart failure, and cardiovascular mortality.
- Specific ECG criteria (QRS duration and axis) may help identify individuals with RBBB who are at higher risk for associated cardiovascular disease.
Abstract:
Cardiovascular abnormalities were identified prospectively in all 70 persons who developed complete right bundle-branch block (RBBB) in The Framingham Study during 18 years of biennial follow-up. Most were hypertensive before the appearance of RBBB. Although the initial appearance of RBBB was usually unaccompanied by overt clinical events, the subsequent incidence of coronary disease and congestive failure was two and one-half and four times greater, respectively, than that in matched control subjects without RBBB. The incidence of cardiovascular disease mortality was almost three times greater in persons who developed RBBB than in an age-matched sample of the population-at-large. This excess of cardiovascular disease mortality was related primarily to the high prevalence of associated cardiovascular abnormalities. Only 21% remained free from clinically apparent cardiovascular abnormalities. A QRS duration of greater than or equal to 130 ms and a QRS axis between -45 degrees and -90 degrees identified those most likely to have associated cardiovascular abnormalities.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy